YUYUE MEDICAL(SZ:002223) Jiang Nan Shi Bao·2025-04-27 07:02Core Viewpoint - Yuyue Medical is focusing on innovation in the healthcare industry by launching new products and forming strategic partnerships to enhance diabetes management and overall health solutions [1][3]. Group 1: Product Launch and Innovation - Yuyue Medical introduced the Anytime 5 series, which is the world's first continuous glucose monitoring (CGM) product capable of monitoring blood glucose for 16 days, featuring a 8.58% MARD accuracy and an integrated design [2]. - The Anytime 5 series leverages AI technology for trend prediction and real-time alerts, aiming to improve diabetes management efficiency and reduce healthcare costs [2]. - The CGM industry is transitioning from a "technical breakthrough" phase to an "ecosystem construction" phase, with the Anytime 5 series expected to lead significant changes in the industry landscape [2]. Group 2: Strategic Partnerships and Market Expansion - Yuyue Medical announced the launch of an OTC retail market leadership plan and deepened strategic partnerships with companies like Wukong Zhili, Jiangsu Mobile, and Jiuzhoutong to enhance market reach and resource integration [3]. - The company introduced the "Anytime Future Partner Recruitment Plan" to involve users in product development, aiming to improve service experience and invest over 10 million yuan in health initiatives [3]. - The spring product launch reflects Yuyue Medical's insight into industry trends and its commitment to providing a new paradigm of "AI + health" for chronic disease management [3].